Skip to main content
HR 3446 116th Congress House Health Advisory bodies Congressional oversight Government studies and investigations Health programs administration and funding Health promotion and preventive care Medical research Medical tests and diagnostic methods Musculoskeletal and skin diseases Organ and tissue donation and transplantation Research administration and funding Research and development

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

Introduced: September 17, 2019 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 25, 2019
Referred to the Subcommittee on Health.
Jun 24, 2019
Referred to the House Committee on Energy and Commerce.
Jun 24, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.

What's happening now June 25, 2019

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 2477 Related bill National Commission on Scleroderma and Fibrotic Diseases Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 32
All 32 Democratic 23 Republican 1
D
Pocan, Mark
Wisconsin · Jul 20, 2020
 D
Crow, Jason
Colorado · Feb 26, 2020
 D
Stevens, Haley M.
Michigan · Jan 15, 2020
 D
Lofgren, Zoe
California · Jan 8, 2020
 D
Pingree, Chellie
Maine · Jan 8, 2020
 D
Gottheimer, Josh
New Jersey · Dec 10, 2019
 D
Smith, Adam
Washington · Dec 10, 2019
Heck, Denny
· Nov 22, 2019
 D
Levin, Mike
California · Nov 21, 2019
 D
Larsen, Rick
Washington · Oct 30, 2019
 D
Lee, Susie
Nevada · Oct 17, 2019
 D
Raskin, Jamie
Maryland · Oct 4, 2019
 D
Neguse, Joe
Colorado · Sep 26, 2019
Delgado, Antonio
· Sep 17, 2019
 D
Espaillat, Adriano
New York · Sep 17, 2019
Perlmutter, Ed
· Sep 17, 2019
 D
Tonko, Paul
New York · Sep 12, 2019
Tipton, Scott
· Sep 10, 2019
 D
Clarke, Yvette D.
New York · Sep 6, 2019
 D
DelBene, Suzan K.
Washington · Sep 6, 2019
 D
Suozzi, Thomas R.
New York · Sep 6, 2019
 D
Welch, Peter
Vermont · Aug 27, 2019
 D
Morelle, Joseph D.
New York · Aug 16, 2019
 D
McGovern, James P.
Massachusetts · Jul 22, 2019
LOWEY, NITA
· Jul 9, 2019
 D
Beatty, Joyce
Ohio · Jun 24, 2019
CLAY, WM.
· Jun 24, 2019
ENGEL, ELIOT
· Jun 24, 2019
 R
Fitzpatrick, Brian K.
Pennsylvania · Jun 24, 2019
 D
Jayapal, Pramila
Washington · Jun 24, 2019
Rice, Kathleen
· Jun 24, 2019
 D
Thompson, Bennie G.
Mississippi · Jun 24, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3446: National Commission on Scleroderma and Fibrotic Diseases Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-3446/
MLA
"H.R. 3446: National Commission on Scleroderma and Fibrotic Diseases Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-3446/.
Bluebook (legal)
H.R. 3446, 116th Cong. (2026), https://openamerica.io/bill/116-HR-3446/.
Markdown link
[H.R. 3446: National Commission on Scleroderma and Fibrotic Diseases Act of 2019](https://openamerica.io/bill/116-HR-3446/)
Report a problem